| 期 |
标题 |
文件 |
| 卷 14, 编号 3 (2023) |
Antidrug effects of GTS201 dipeptide, an imitation of the second bird BDNF, in morphine-addicted rats |
(Rus)
(Eng)
|
|
Konstantinopolskii M., Kolik L., Chernyakova I., Sazonova N., Gudasheva T.
|
| 卷 14, 编号 3 (2023) |
Antidyskinetic activity of new derivatives of inydazol-4,5-dicarbonic acid in a parkinsonism experimental model due to administration of 6-hydroxydopapine |
(Rus)
(Eng)
|
|
Dergachev V., Yakovleva E., Brusina M., Bychkov E., Piotrovskiy L., Shabanov P.
|
| 卷 16, 编号 2 (2025) |
Exploring novel pharmacological approaches to acute hypoxic preconditioning |
(Rus)
(Eng)
|
|
Mosin O., Belenky A., Stepanov D., Evseev A.
|
| 卷 16, 编号 2 (2025) |
Hippocampal metabolism of biogenic metals and selenium in patients with chronic manganese intoxication |
(Rus)
(Eng)
|
|
Klimenko D., Demidova E., Varioshkin P., Shemaev M., Grigorieva N., Belyakova N., Karpova I., Lapina N.
|
| 卷 15, 编号 4 (2024) |
Kisspeptins Kiss1 and Kiss2 in fish modulate corticoliberin and gonadoliberin gene expression in brain structures of Danio rerio |
(Rus)
(Eng)
|
|
Lizunov A., Blazhenko A., Komlev A., Petrova P., Khokhlov P., Bychkov E., Shabanov P.
|
| 卷 15, 编号 4 (2024) |
Lateral characteristics of oxytocin distribution in the mouse brain following intranasal peptide administration |
(Rus)
(Eng)
|
|
Karpova I., Litvinova M., Tissen I., Bychkov E., Shabanov P.
|
| 卷 15, 编号 3 (2024) |
l-DOPA for the prevention and acceleration of the reversal of neurogenic dystrophic damage to internal organs |
(Rus)
|
|
Zabrodin O.
|
| 卷 16, 编号 1 (2025) |
Methamphetamine as a street drug: effects, addiction, and associated risk factors |
(Eng)
|
|
Urakov A.
|
| 卷 15, 编号 3 (2024) |
γ-Secretase in the pathogenesis of Alzheimer’s disease and therapeutic potential of its modulators |
(Rus)
|
|
Vilyaninov V., Vashchenko V., Shabanov P.
|
| 卷 15, 编号 1 (2024) |
Aquarium fish and temperature neuropharmacology: Update |
(Rus)
|
|
Urakov A., Fisher E., Lebedev A., Shabanov P.
|
| 卷 14, 编号 2 (2023) |
Influence of oxytocin on the central nervous system by different routes of administration |
(Rus)
|
|
Litvinova M., Tissen l., Lebedev A., Bychkov E., Karpova I., Shabanov P.
|
| 卷 16, 编号 1 (2025) |
New generation antihypoxants: alkaline hydrogen peroxide solutions as medical oxygen gas generators |
(Rus)
(Eng)
|
|
Urakova N., Urakov A.
|
| 卷 15, 编号 3 (2024) |
Antioxidant effects of 2-ethylthiobenzimidazole and a complex of succinic acid salts in rats pre-trained to hypoxia with acute oxygen starvation |
(Rus)
(Eng)
|
|
Kozhurin M., Zarubina I., Shabanov P.
|
| 卷 16, 编号 3 (2025) |
The battle over “food addiction”. Translation into Russian |
(Rus)
|
|
Lustig R.
|
| 卷 16, 编号 3 (2025) |
Therapeutic approaches to psychoses induced by synthetic cathinones (“bath salts”): findings from a pilot observational study |
(Rus)
|
|
Vinnikova M., Severtsev V.
|
| 卷 15, 编号 3 (2024) |
Effects of the new ghrelin receptor antagonist agrelax on compulsive overeating induced by acute and chronic stress in rats |
(Rus)
(Eng)
|
|
Nadbitova N., Pyurveev S., Netesa M., Lebedev A., Shabanov P.
|
| 卷 14, 编号 2 (2023) |
Effect of synthetic folic acid surplus on neurological symptoms in offspring |
(Rus)
|
|
Kachanov D., Tikchonova A., Orlova V., Dzhanbekova K., Fedotova M., Karabanova A.
|
| 卷 15, 编号 2 (2024) |
Effects of unilateral cortical inactivation on monoamine metabolism in symmetrical forebrain areas of white outbred mice |
(Rus)
|
|
Karpova I., Mikheyev V., Bychkov E., Shabanov P.
|
| 卷 14, 编号 4 (2023) |
Effect of experimental therapy on the gas and acid–base composition of the blood in the dynamics of toxic pulmonary edema |
(Rus)
|
|
Torkunov P., Zemlyanoy A., Torkunova T., Shabanov P.
|
| 卷 14, 编号 2 (2023) |
Effect of Orostachys spinosa dry extract on white rat behavior in tests with positive reinforcement |
(Rus)
|
|
Razuvaeva Y., Bayanduyeva Y., Toropova A., Nikolaeva I.
|
| 卷 13, 编号 3 (2022) |
Possible autoimmune mechanisms of regulation of rat behavior in the “open field” test |
(Rus)
|
|
Baturin V., Beyer E., Baturina M.
|
| 卷 16, 编号 3 (2025) |
Inflammatory biomarkers as a tool for personalized therapy in alcohol-related disorders |
(Rus)
|
|
Sokolova S., Skryabin V., Ardamatskaya L., Masyakin A.
|
| 卷 15, 编号 2 (2024) |
Hypothermic effect of antihypoxant 2-aminobenzotiazole |
(Rus)
|
|
Klimenko D., Demidova E., Karpova I., Marysheva V., Evdokimova N., Shchukina N., Ganapolsky V., Shabanov P.
|
| 卷 14, 编号 1 (2023) |
Supplementing traditional drug formulation with the “needed” gases opens the way for the development of a new generation of drugs |
(Rus)
|
|
Urakov A., Shabanov P., Gurevich K., Lovtsova L.
|
| 卷 14, 编号 4 (2023) |
Changes in monoamine metabolism in the brain during unilateral cortical spreading depression in BALB/c mice |
(Rus)
|
|
Karpova I., Mikheev V., Bychkov E., Shabanov P.
|
| 卷 15, 编号 4 (2024) |
Infrared video recording of local skin temperature changes at the injection site as a prospective diagnostic document (in memory of Professor Edward Francis John Ring) |
(Rus)
|
|
Urakov A.
|
| 卷 13, 编号 4 (2022) |
I.P. Pavlov as an experimental pharmacologist (to the 275th anniversary of the Department of Pharmacology of the Military Medical Academy) |
(Rus)
|
|
Shabanov P.
|
| 卷 14, 编号 3 (2023) |
The history of the Department of Pharmacology, Institute of Experimental Medicine (to the 100th anniversary of the department) |
(Rus)
|
|
Shabanov P.
|
| 卷 13, 编号 3 (2022) |
On the history of the study of the nervous trophism mechanisms, disorders, and correction in the Institute of Experimental Medicine (100th anniversary of the S.V. Anichkov Department of Pharmacology) |
(Rus)
|
|
Zabrodin O., Strashnov V.
|
| 卷 16, 编号 2 (2025) |
Cardioprotective effect of dexmedetomidine for prevention of neurogenic myocardial dystrophy in cardiac and non-cardiac surgical patients |
(Rus)
|
|
Zabrodin O., Strashnov V.
|
| 卷 14, 编号 4 (2023) |
Department of Pharmacology of the Military Medical Academy in the 21st century: New achievements based on historical traditions (2000–2023) |
(Rus)
|
|
Shabanov P.
|
| 卷 14, 编号 1 (2023) |
Department of Pharmacology at the Imperial Medical and Surgical Academy: The first 100 years (1798–1898) |
(Rus)
|
|
Shabanov P.
|
| 卷 14, 编号 2 (2023) |
Department of Pharmacology of the Imperial Medical and Surgical (Military Medical) Academy: History of the second century of existence (1899–2000) |
(Rus)
|
|
Shabanov P.
|
| 卷 15, 编号 4 (2024) |
Acid-base composition of mice blood during the progression of toxic pulmonary edema |
(Rus)
|
|
Torkunov P., Zemlyanoy A., Chepur S., Torkunova O., Shabanov P.
|
| 卷 14, 编号 4 (2023) |
Kisspeptin reduces sexual dysfunction in a rat model of posttraumatic stress disorder |
(Rus)
|
|
Tissen I., Lebedev A., Tsikunov S., Shabanov P.
|
| 卷 13, 编号 4 (2022) |
The cognitive stability of an elderly human is guaranteed by his lifelong motor activity |
(Rus)
|
|
Radchenko A.
|
| 卷 16, 编号 2 (2025) |
Commentary on the use of statistical tests in experimental pharmacological studies |
(Rus)
|
|
Khokhlov P., Nuzhnova A., Kostina M., Blazhenko A., Bychkov E.
|
| 卷 15, 编号 2 (2024) |
Correction of compulsive overeating in rats after maternal deprivation in early age using a new antagonist of OX1 receptors |
(Rus)
|
|
Lebedev A., Pyurveev S., Nadbitova N., Lukashkova V., Lebedev V., Bychkov E., Shabanov P.
|
| 卷 16, 编号 3 (2025) |
Cross-sectional study of the risk of cognitive impairment associated with COVID-19 and a prognostic scale for psychopharmacotherapy selection in outpatient settings |
(Rus)
|
|
Sorokin M., Gerasimchuk E., Lutova N., Zubova E.
|
| 卷 15, 编号 4 (2024) |
Copper-dependent cell death (cuproptosis): perspectives for pharmacological correction in human diseases |
(Rus)
|
|
Vashchenko V., Chuklovin A., Shabanov P.
|
| 卷 16, 编号 2 (2025) |
Professor Petr D. Shabanov: a celebrated leader in St. Petersburg pharmacology (on his 70th anniversary) |
(Rus)
|
|
Lebedev A.
|
| 卷 14, 编号 3 (2023) |
Method and technology for drug repurposing based on changes in the physicochemical properties of dosage forms: experience of use in Russia |
(Rus)
|
|
Urakov A.
|
| 卷 16, 编号 2 (2025) |
Mechanism of cuproptosis in pathogenesis of Parkinson’s disease |
(Rus)
|
|
Vashchenko V., Chukhlovin A., Shabanov P.
|
| 卷 15, 编号 3 (2024) |
MicroRNA-30a-5p as a target for pharmacological correction of pathological conditions of the nervous system |
(Rus)
|
|
Airapetov M., Eresko S., Shamayeva S., Lebedev A., Bychkov E., Shabanov P.
|
| 卷 16, 编号 1 (2025) |
Molecular mechanisms of interaction between ferroptosis and cuproptosis in ischemic stroke. Pharmacological perspectives on preventing brain dysfunction |
(Rus)
|
|
Vashchenko V., Sorokoletova E., Shabanov P.
|
| 卷 14, 编号 1 (2023) |
Monoaminergic effects of the unilateral blockade of orexin receptors (OX1R) in the enlarged amygdala under psychostimulant action |
(Rus)
(Eng)
|
|
Karpova I., Bychkov E., Lebedev A., Shabanov P.
|
| 卷 15, 编号 2 (2024) |
Morphological changes in the hippocampus of the rat brain in ischemia and in conditions of combined preconditioning |
(Rus)
(Eng)
|
|
Novikov V., Levchenkova O., Korneva J.
|
| 卷 15, 编号 3 (2024) |
The scientific school of pharmacology of S.V. Anichkov, an academician of the USSR academy of medical sciences |
(Rus)
|
|
Khnychenko L.
|
| 卷 14, 编号 1 (2023) |
A new ghrelin receptor antagonist agrelax participates in the control of emotional-explorative behavior and anxiety in rats |
(Rus)
(Eng)
|
|
Lebedev A., Lukashkova V., Pshenichnaya A., Bychkov E., Lebedev V., Rusanovsky V., Shabanov P.
|
| 卷 16, 编号 3 (2025) |
Rationale for integrated nutrient support in schizophrenia: a brief review |
(Rus)
|
|
Zhilyaeva T., Mazo G.
|
| 卷 14, 编号 4 (2023) |
Opioid, cannabinoid, cocaine, and methamphetamine epidemics: History, risk factors associated with them, and characteristics of drug action |
(Rus)
(Eng)
|
|
Urakov A., Shabanov P.
|
| 卷 15, 编号 1 (2024) |
Effectiveness of ethylmethylhydroxypyridine succinate in alcohol withdrawal |
(Rus)
|
|
Yakusheva E., Shchulkin A., Abalenikhina Y.
|
| 卷 15, 编号 1 (2024) |
Pathogenetic and pharmacodynamic features of succinic acid derivative application for various diseases of the cardiovascular and nervous systems |
(Rus)
|
|
Kim A., Shustov E., Ganapolsky V.
|
| 卷 13, 编号 4 (2022) |
Prospects for the use of bovhyaluronidase azoxymer in the post-COVID period after a severe COVID-19: A clinical case |
(Rus)
|
|
Sergeeva T., Kachanov D., Belogurova E., Batalova A., Pavlysh A.
|
| 卷 16, 编号 1 (2025) |
Prospects of pharmacological regulation of physiological adaptation mechanisms in cerebrovascular insufficiency |
(Rus)
|
|
Novikov V., Pozhilova E., Usacheva N., Zagnet K.
|
| 卷 15, 编号 4 (2024) |
Placental causes of fetal growth restriction and treatment methods |
(Rus)
|
|
Blazhenko A., Pachuliya O., Bespalova O., Kogan I.
|
| 卷 15, 编号 2 (2024) |
Reinforcing systems of the brain and quantification of their work |
(Rus)
(Eng)
|
|
Shabanov P., Likhtman Y., Lebedev A.
|
| 卷 14, 编号 3 (2023) |
Why does a warm-blooded organism rapidly regulates body temperature in the thermoneutral zone |
(Rus)
|
|
Luchakov Y., Shabanov P.
|
| 卷 14, 编号 3 (2023) |
The use of Cytoflavin in the post-withdrawal period in patients with alcohol dependence |
(Rus)
|
|
Vostrikov V.
|
| 卷 15, 编号 1 (2024) |
Antihypoxic effect of almid-containing metal-complex compounds in the experiment |
(Rus)
(Eng)
|
|
Evseev A., Mosin O., Evseeva M., Pereverzev V., Pravdivtsev V., Stepanov D., Aleksashkin S.
|
| 卷 15, 编号 4 (2024) |
Professor P.P. Denisenko and his school: a scientific biography and personal recollections |
(Rus)
|
|
Shabanov P.
|
| 卷 14, 编号 4 (2023) |
The developing brain in the formation of oxidant and antioxidant systems |
(Rus)
(Eng)
|
|
Shabanov P., Zarubina I.
|
| 卷 15, 编号 2 (2024) |
Objective predictors for delirium tremens based on physiological and metabolic parameters |
(Rus)
|
|
Utkin S., Buzik O., Burtsev A.
|
| 卷 16, 编号 2 (2025) |
Risks associated with hypoglycemic pharmacotherapy in elderly patients with neurological and psychiatric disorders |
(Rus)
|
|
Novikov V., Zagnet K., Pozhilova E.
|
| 卷 15, 编号 1 (2024) |
Role of bioenergetic hypoxia in the morphological transformation of the myocardium during vibration disease |
(Rus)
(Eng)
|
|
Vorobieva V., Levchenkova O., Lenskaya K.
|
| 卷 15, 编号 2 (2024) |
Sedative effect of U-49900 (3,4-dichloro-N- (2-(diethylamino)cyclohexyl)-N-methyl-benzamide) in adult Zebrafish |
(Rus)
|
|
Kolesnikova T., Shevyrin V., Khatsko S., Kalueff A.
|
| 卷 13, 编号 3 (2022) |
Selective antagonists of calcium-permeable GluA1 AMPA-receptors as potential antiaddictive agents |
(Rus)
|
|
Potapkin A., Gmiro V., Shabanov P.
|
| 卷 13, 编号 3 (2022) |
Ghrelin levels in different brain regions in Danio rerio exposured to stress |
(Rus)
|
|
Blazhenko A., Khokhlov P., Lebedev A., Bychkov E., Kazakov S., Shabanov P.
|
| 卷 15, 编号 1 (2024) |
Creator of the concept of antihypoxants and actoprotectors: On the occasion of the 100th anniversary of Professor V.M. Vinogradov |
(Rus)
|
|
Shabanov P.
|
| 卷 15, 编号 2 (2024) |
Ethyl alcohol: Influence on the dynamics of blood supply of skin and other soft tissues during their sudden cooling |
(Rus)
|
|
Urakov A.
|
| 卷 14, 编号 2 (2023) |
Comparison of anxiolytic effects of mammalian and bony fish kisspeptins in Danio rerio |
(Rus)
(Eng)
|
|
Goltz V., Lebedev A., Blazhenko A., Lebedev V., Bayramov A., Khokhlov P., Bychkov E., Pyurveev S., Kazakov S., Shabanov P.
|
| 卷 16, 编号 1 (2025) |
Comparison of the antiparkinsonian activity of N-decyltropine (IEM-1556) and levodopa in rats with rotenone-induced parkinsonism |
(Rus)
|
|
Gmiro V., Serdyuk S., Shabanov P.
|
| 卷 15, 编号 2 (2024) |
Talented biochemical pharmacologist Professor Irina V. Zarubina |
(Rus)
|
|
Shabanov P.
|
| 卷 15, 编号 4 (2024) |
Improvement of interhemispheric interaction by polyprenol and nootropic agents in a visual evoked potential model in rabbits |
(Rus)
|
|
Kuznetsova N., Shabanov P.
|
| 卷 14, 编号 2 (2023) |
Uridine increases endurance and improves the rehabilitation of experimental animals after physical performance |
(Rus)
(Eng)
|
|
Krylova I., Selina E.
|
| 卷 15, 编号 1 (2024) |
Pharmacological neuroprotection in cerebrovascular insufficiency: Possible approaches |
(Rus)
|
|
Novikov V., Pozhilova E.
|
| 卷 14, 编号 1 (2023) |
Chronobiological aspects of the anti-stress effect of anxiolytics |
(Rus)
|
|
Ovanesov K., Beyer E., Kaminskaya O., Elbekyan K., Skornyakov A., Aleksanova E.
|
| 卷 16, 编号 1 (2025) |
Corresponding Member of the Russian Academy of Medical Sciences Irina S. Zavodskaya (on the 100th birth anniversary) |
(Rus)
|
|
Khnychenko L.
|
| 卷 14, 编号 1 (2023) |
Experimental therapy for toxic pulmonary edema caused by inhalation poisoning with nitrogen oxides |
(Rus)
|
|
Torkunov P., Zemlyanoy A., Varlashova M., Chepur S., Torkunova O., Shabanov P.
|
| 卷 14, 编号 1 (2023) |
Experimental treatment of induced fetal retardation in model animals |
(Rus)
|
|
Bespalova O., Blazhenko A.
|
| 卷 15, 编号 1 (2024) |
Erythropoietin as antihypoxic cytokine |
(Rus)
|
|
Lyubimov A., Bykova D., Tarachteev A., Ivchenko E., Efimov S.
|
| 卷 13, 编号 4 (2022) |
Effectiveness of sodium nucleospermate for the development of embryos and larvae of Danio rerio |
(Rus)
|
|
Blazhenko A., Lebedev A., Tapilskaya N., Proshin S., Shabanov P.
|
| 卷 13, 编号 4 (2022) |
Effects of fullerene C60 with antihypoxants |
(Rus)
|
|
Marysheva V., Shabanov P.
|
| 1 - 83 的 83 信息 |
|
